Effect of Activated Charcoal on the Pharmacokinetics of LY2216684 in Healthy Subjects.
Phase of Trial: Phase I
Latest Information Update: 23 Sep 2011
At a glance
- Drugs Charcoal; Edivoxetine
- Indications Attention-deficit hyperactivity disorder; Depressive disorders
- Focus Pharmacokinetics
- Sponsors Eli Lilly
- 23 Sep 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 24 Aug 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 28 Jul 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.